5 havaittiin 12 viikon hoidon aikana noin 41%: lla Raptivaa saaneista potilaista ja 24%: lla plaseboa saaneista potilaista. ###>In large placebo-controlled clinical studies, these reactions were observed in approximately 41% of Raptiva-treated patients and 24% in placebo-treated patients over 12 weeks of treatment.